novo wegovy - Search News

News

Lilly, Novo Nordisk and Wegovy

Reuters on MSN · 2d

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial. The data is the first head-to-head trial comparing the wildly popular medicines,

Indianapolis Business Journal · 17h

Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last month.

Bloomberg on MSN · 3d

Lilly’s Zepbound Trims More Belly Fat Than Novo’s Wegovy

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s Wegovy in the first head-to-head study of the rival medicines.

Novo Nordisk's latest bet on obesity pills

BioPharma Dive · 10h

Novo to work with Septerna in hunt for oral obesity drugs

The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the latest deal Novo has struck to expand its obesity pipeline.

Reuters on MSN · 21h

Novo Nordisk Strikes $2.2 Billion Deal With Septerna to Develop New Obesity Treatments

COPENHAGEN (Reuters) -Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule medicines for obesity, type 2 diabetes and other cardio-metabolic diseases that could be worth up to $2.2 billion for Septerna, they said on Wednesday.

Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Sapterna

Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.

Zepbound vs. Wegovy: Here's which weight loss drug worked best in first trial

People taking Zepbound, Eli Lilly’s obesity drug, lost almost 50% more weight than individuals using Novo Nordisk’s ...

2don MSN

This Drug Is Nearly 50 Percent More Effective Than Wegovy

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...

3h

Ignore The Noise - Novo Nordisk Is A Clear Buy

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results